ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

DuPont invests big in probiotics

by Michael McCoy
November 7, 2016 | APPEARED IN VOLUME 94, ISSUE 44

DuPont will spend $100 million to expand probiotics production capacity in the U.S. The firm, which got into the business with its 2011 acquisition of Danisco, says it will boost capacity at plants in Madison, Wis., and Rochester, N.Y., by 70%. The two facilities are already being expanded as part of an earlier project. DuPont says consumers are increasingly turning to probiotics—beneficial strains of bacteria and yeast—to proactively take care of their health.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment